These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26498568)

  • 1. Core-Scaffold-Inspired Asymmetric Synthesis of Polysubstituted Chiral Hexahydropyridazines that Potently Inhibit Breast Cancer Cell Proliferation by Inducing Apoptosis.
    Leng HJ; Peng F; Zingales S; Huang W; Wang B; Zhao Q; Zhou R; He G; Peng C; Han B
    Chemistry; 2015 Dec; 21(50):18100-8. PubMed ID: 26498568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organocatalytic cascade reaction for the asymmetric synthesis of novel chroman-fused spirooxindoles that potently inhibit cancer cell proliferation.
    Zhou R; Wu Q; Guo M; Huang W; He X; Yang L; Peng F; He G; Han B
    Chem Commun (Camb); 2015 Aug; 51(66):13113-6. PubMed ID: 26186061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and SAR study of 2-(1-propylpiperidin-4-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) for the treatment of cancer.
    Zhu Q; Wang X; Hu Y; He X; Gong G; Xu Y
    Bioorg Med Chem; 2015 Oct; 23(20):6551-9. PubMed ID: 26422786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organocatalytic Asymmetric Synthesis of Spiro-oxindole Piperidine Derivatives That Reduce Cancer Cell Proliferation by Inhibiting MDM2-p53 Interaction.
    Yang MC; Peng C; Huang H; Yang L; He XH; Huang W; Cui HL; He G; Han B
    Org Lett; 2017 Dec; 19(24):6752-6755. PubMed ID: 29210587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of 4-amidobenzimidazole acridine derivatives as dual PARP and Topo inhibitors for cancer therapy.
    Yuan Z; Chen S; Chen C; Chen J; Chen C; Dai Q; Gao C; Jiang Y
    Eur J Med Chem; 2017 Sep; 138():1135-1146. PubMed ID: 28763648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of AMF-26, an antitumor agent for inhibition of the Golgi system, targeting ADP-ribosylation factor 1.
    Shiina I; Umezaki Y; Ohashi Y; Yamazaki Y; Dan S; Yamori T
    J Med Chem; 2013 Jan; 56(1):150-9. PubMed ID: 23214926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis in MDA-MB-231 breast cancer cells by a PARP1-targeting PROTAC small molecule.
    Zhao Q; Lan T; Su S; Rao Y
    Chem Commun (Camb); 2019 Jan; 55(3):369-372. PubMed ID: 30540295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
    Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; São-José Nascimento M
    Eur J Med Chem; 2010 Dec; 45(12):5732-8. PubMed ID: 20934235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells.
    Balakrishna MS; Suresh D; Rai A; Mague JT; Panda D
    Inorg Chem; 2010 Oct; 49(19):8790-801. PubMed ID: 20812680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI001) with apoptosis-inducing mechanisms in breast cancer.
    Liu B; Fu L; Zhang C; Zhang L; Zhang Y; Ouyang L; He G; Huang J
    Oncotarget; 2015 Mar; 6(9):6762-75. PubMed ID: 25742792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis-inducing effect of a palladium(II) saccharinate complex of terpyridine on human breast cancer cells in vitro and in vivo.
    Ari F; Cevatemre B; Armutak EI; Aztopal N; Yilmaz VT; Ulukaya E
    Bioorg Med Chem; 2014 Sep; 22(17):4948-54. PubMed ID: 25047941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-pot catalytic enantioselective synthesis of tetrahydropyridines via a nitro-Mannich/hydroamination cascade.
    Barber DM; Sanganee HJ; Dixon DJ
    Org Lett; 2012 Oct; 14(20):5290-3. PubMed ID: 23039069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo.
    Carrasco E; Álvarez PJ; Melguizo C; Prados J; Álvarez-Manzaneda E; Chahboun R; Messouri I; Vázquez-Vázquez MI; Aránega A; Rodríguez-Serrano F
    Eur J Med Chem; 2014 May; 79():1-12. PubMed ID: 24704691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of selenazolopyridine derivatives with capability to induce apoptosis in human breast carcinoma MCF-7 cells through scavenge of intracellular ROS.
    Zhou M; Ji S; Wu Z; Li Y; Zheng W; Zhou H; Chen T
    Eur J Med Chem; 2015; 96():92-7. PubMed ID: 25874334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of intrinsic apoptosis pathway in colon cancer HCT-116 cells by novel 2-substituted-5,6,7,8-tetrahydronaphthalene derivatives.
    Gamal-Eldeen AM; Hamdy NA; Abdel-Aziz HA; El-Hussieny EA; Fakhr IM
    Eur J Med Chem; 2014 Apr; 77():323-33. PubMed ID: 24657569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel enantioselective alkylation and its application to the synthesis of an anticancer agent.
    Kuo SC; Chen F; Hou D; Kim-Meade A; Bernard C; Liu J; Levy S; Wu GG
    J Org Chem; 2003 Jun; 68(12):4984-7. PubMed ID: 12790617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantioselective Synthesis of Planar Chiral Ferrocifens that Show Chiral Discrimination in Antiproliferative Activity on Breast Cancer Cells.
    Cunningham L; Wang Y; Nottingham C; Pagsulingan J; Jaouen G; McGlinchey MJ; Guiry PJ
    Chembiochem; 2020 Oct; 21(20):2974-2981. PubMed ID: 32453493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile construction of structurally diverse thiazolidinedione-derived compounds via divergent stereoselective cascade organocatalysis and their biological exploratory studies.
    Zhang Y; Wang S; Wu S; Zhu S; Dong G; Miao Z; Yao J; Zhang W; Sheng C; Wang W
    ACS Comb Sci; 2013 Jun; 15(6):298-308. PubMed ID: 23614347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth.
    Snyder RM; Yu W; Jia L; Sanders BG; Kline K
    Nutr Cancer; 2008; 60(3):401-11. PubMed ID: 18444175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric synthesis of tetrahydropyridines via an organocatalytic one-pot multicomponent Michael/aza-Henry/cyclization triple domino reaction.
    Blümel M; Chauhan P; Hahn R; Raabe G; Enders D
    Org Lett; 2014 Nov; 16(22):6012-5. PubMed ID: 25379786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.